The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

LONDON, Dec 23 (Reuters) - Novo Nordisk's (NOVOb.CO) newly approved weight-loss pill version of Wegovy will be a test case ...

Novo Nordisk shares jumped nearly 8% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

As Novo Nordisk’s weight-loss pill Wegovy (semaglutide) readies for a launch in the United States early January, it will be a ...

Wegovy's new pill has been approved in the US, offering a needle-free option with a lower starting price than injections.